CIK: 0001831942
Total reported value
$1.7B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Merus N V | Stock-Other | 10.73% | — | +21.18% | |
| 2 | ACRS | Aclaris Therapeutics INC | Stock-Other | 8.91% | — | -13.39% | |
| 3 | BLU | Bellus Health INC | Stock-Other | 8.66% | — | +80.43% | |
| 4 | OPHTEUR | Iveric Bio INC | Stock-Other | 8.33% | — | -31.15% | |
| 5 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 8.21% | -2.59% | +10.32% | |
| 6 | CYTK | Cytokinetics INC | Stock-Healthcare | 7.03% | — | +21.31% | |
| 7 | KPTIEUR | Karyopharm Therapeutics INC | Stock-Other | 5.86% | — | — | |
| 8 | COGT | Cogent Biosciences INC | Stock-Other | 5.86% | +1.24% | +53.45% | |
| 9 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 3.99% | — | +5.88% | |
| 10 | VRDN | Viridian Therapeutics INC | Stock-Other | 3.93% | — | +12.23% | |
| 11 | 1T7 | Tricida INC | Stock-Other | 3.20% | — | +39.90% | |
| 12 | STSAUSD | Satsuma Pharmaceuticals INC | Stock-Other | 3.15% | — | — | |
| 13 | VTGNUSD | Vistagen Therapeutics INC | Stock-Other | 2.80% | — | +19.28% | |
| 14 | KURA | Kura Oncology INC | Stock-Other | 2.79% | — | — | |
| 15 | CCCC | C4 Therapeutics INC | Stock-Other | 2.61% | — | — | |
| 16 | VTLUSD | Immunic INC | Stock-Other | 2.25% | — | — | |
| 17 | CELC | Celcuity INC | Stock-Other | 1.92% | — | — | |
| 18 | CLDX | Celldex Therapeutics INC | Stock-Other | 1.83% | +0.31% | — | |
| 19 | PTGX | Protagonist Therapeutics INC | Stock-Other | 1.76% | -2.62% | EXIT | |
| 20 | TNYA | Tenaya Therapeutics INC | Stock-Other | 1.35% | — | — | |
| 21 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 1.03% | — | — | |
| 22 | GNCAQ | Genocea Biosciences INC | Stock-Other | 0.86% | — | — | |
| 23 | IVA | Inventiva SA - Adr | Stock-Other | 0.67% | — | — | |
| 24 | DYN | Dyne Therapeutics INC | Stock-Other | 0.66% | — | — | |
| 25 | PMVP | Pmv Pharmaceuticals INC | Stock-Other | 0.58% | — | — | |
| 26 | ✓ | Bcls Acquisition CORP | Stock-Other | 0.55% | — | — | |
| 27 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.49% | — | — |